Nuwellis (NUWE) Return on Capital Employed Growth (1y) (2013 - 2026)
Nuwellis (NUWE) Return on Capital Employed Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.27 Bn | 175.98 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.81 Bn | 125.93 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.63 Bn | 99.41 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.84 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 28.31 Bn | 26.03 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.35 Bn | 2.07 Bn | 125.00 |
| 10 | Nuwellis | 116,651.13 | -1.97 Mn | 1.68 Mn | -28,543.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28,543.00 |
| Dec 31, 2025 | -8,481.00 |
| Sep 30, 2025 | 10,658.00 |
| Jun 30, 2025 | 33,907.00 |
| Mar 31, 2025 | 26,101.00 |
| Dec 31, 2024 | 4,578.00 |
| Sep 30, 2024 | -14,767.00 |
| Jun 30, 2024 | -42,730.00 |
| Mar 31, 2024 | -31,805.00 |
| Dec 31, 2023 | -13,551.00 |
| Sep 30, 2023 | -7,468.00 |
| Jun 30, 2023 | -5,766.00 |
| Mar 31, 2023 | -3,122.00 |
| Dec 31, 2022 | -3,435.00 |
| Sep 30, 2022 | -3,279.00 |
| Jun 30, 2022 | -2,283.00 |
| Mar 31, 2022 | -45.00 |
| Dec 31, 2021 | 2,570.00 |
| Sep 30, 2021 | 4,364.00 |
| Jun 30, 2021 | 14,511.00 |